What is Clinical Costing?

Clinical costing is the systematic process of identifying, calculating, and reporting the actual cost of delivering healthcare to each individual patient. Unlike traditional financial accounting — which groups expenses at the departmental or facility level — clinical costing traces every resource consumed during a patient’s care journey and attaches a precise cost to it.

This includes direct costs such as medications dispensed, diagnostic tests ordered, surgical supplies used, nursing hours spent, and physician time allocated — as well as indirect overhead costs (facility maintenance, administration, utilities) that are apportioned to patient encounters using standardized allocation methodologies.

Patient-Level Costing (PLICS): The Core Concept

At the heart of clinical costing is Patient-Level Information and Costing Systems (PLICS). This approach requires that every cost element — from a single tablet dispensed to a CT scan conducted — be traced and attributed to a specific patient encounter. The result is a complete, itemized cost profile for every inpatient admission, outpatient visit, or emergency presentation.

PLICS moves healthcare finance from approximate averages to precise intelligence. A hospital can no longer simply say “our ICU costs AED 2 million per month.” It must now demonstrate exactly what was spent on each of the patients in that ICU, and why.

Why Is the UAE Acting Now? The Bigger Picture

The introduction of mandatory clinical costing in Abu Dhabi is not an isolated regulation — it is the cornerstone of a broader strategic transformation toward Value-Based Healthcare (VBHC).

The UAE healthcare system is under significant structural pressures: rising patient volumes driven by population growth and medical tourism, escalating operational costs, increasing complexity of care, and the need to optimize reimbursement under insurance-dominated payment models. Traditional cost management approaches have proven insufficient.

“Implementation of the Clinical Costing Road Map for the Emirate of Abu Dhabi is a continuation of the Clinical Costing and Value Based Funding Framework Project, developing a comprehensive framework for the Emirate of Abu Dhabi through healthcare provider engagement.”
 — Department of Health, Abu Dhabi (DOH Official Portal)

The Shift to DRG-Based Reimbursement

A critical driver is the transition to Diagnosis-Related Group (DRG) billing. Under DRG models, insurers and government payers pay a fixed, predetermined rate for a diagnosis or procedure — regardless of the actual resources a provider consumed. If your facility does not practice accurate clinical costing, you cannot know whether a particular DRG payment covers your costs, generates profit, or represents a loss. Clinical costing closes this knowledge gap.

 Abu Dhabi’s 15-Month Investment

The DOH undertook a 15-month Clinical Costing and Value Based Funding Framework Project — completed in August 2024 — with over 50 engagement sessions involving internal and external stakeholders. The Clinical Costing Standard was the direct output of this process, making it one of the most rigorously developed healthcare finance regulations in the GCC.

The DOH Clinical Costing Framework: 3 Pillars

The Abu Dhabi Clinical Costing regulation is built on three interlocking documents that together define what must be done, how it must be done, and in what format data must be submitted.

The Clinical Costing Standard

Sets the overarching methodology, principles, and requirements. Defines cost centers, cost types, allocation rules, and the reconciliation framework. This is the “what” of clinical costing — the binding regulatory requirement.

The Clinical Costing Guideline

Provides step-by-step practical guidance on implementing the Standard. Explains how to classify cost centers, select allocation statistics, create costing products, and link clinical data to financial data. This is the “how.”

The Technical Data Document

Details the technical specifications: XML schema requirements, data formats, validation rules, and the Shafafiya submission protocol. Submissions that fail to conform to these specifications will be rejected.

Compliance Timeline: What Happened and What’s Next

The implementation timeline for Abu Dhabi’s clinical costing mandate has evolved since its announcement in late 2024. Understanding this history — and where the regulation currently stands — is essential for every provider.

November 2024

DOH Releases Clinical Costing Standard & Guidelines

The Department of Health Abu Dhabi officially published the Abu Dhabi Clinical Costing Standard Version 1.0 alongside accompanying guidelines. This initiated the mandatory compliance journey for all licensed providers.

December 16, 2024 — Circular 242/2024

First Extension Granted: Deadline Moved to July 1, 2025

Acknowledging the unprecedented complexity of implementing patient-level costing across an entire healthcare ecosystem, the DOH moved the inaugural submission deadline from April 1–15, 2025 to July 1, 2025. This was explicitly positioned as a one-time accommodation.

July 2, 2025 — Circular 110/2025

Final Extension: Deadline Moved to September 1–30, 2025

The DOH issued a final extension for the inaugural submission, setting the window at September 1–30, 2025. This was declared the absolute last accommodation — no further extensions would be granted. All future annual submissions proceed on schedule.

September 1–30, 2025

FY2024 Data Submission Window

The final, non-negotiable window for submitting Financial Year 2024 patient-level cost data through the Shafafiya portal. Facilities that missed this deadline face immediate penalties. Designating a clinical costing contact person was mandatory prior to this window.

2026 and Beyond

Annual Submissions Proceed on Schedule

From FY2025 data onwards, annual clinical costing submissions proceed on the standard April schedule with no further extensions. Providers must have robust, automated systems in place to meet ongoing annual deadlines.

Ongoing — Current Status

The 6-Stage Clinical Costing Process

The Abu Dhabi Clinical Costing Standard mandates a six-stage methodology for calculating and reporting patient-level costs. Each stage builds on the previous, forming a structured pipeline from raw financial data to a validated, regulatorily-compliant submission.

STAGE 01

Identify & Classify Expenses

Gather all general ledger expenses, including third-party costs. Map every expense line to standardized Cost Types (e.g., staff costs, consumables, overheads, depreciation) as defined in Appendix 2 of the DOH Standard. This is the foundation of the entire process.

STAGE 02

Create Cost Ledger & Cost Centers

Establish a cost center accounting structure. Classify every cost center as either a Direct Cost Center (patient-facing, e.g., wards, theatres, outpatient clinics) or an Overhead Cost Center (support functions, e.g., HR, IT, facilities). Map cost centers to standardized reporting groups.

STAGE 03

Allocate Overheads Using Statistics

Distribute overhead costs to direct cost centers using appropriate allocation statistics (e.g., headcount, floor area, FTE, activity volumes). Statistics must reflect a logical causal relationship between the overhead and the recipient departments. Apply reciprocal or step-down allocation methods.

STAGE 04

Create Costing Products

Define all costing products — the granular units of care from which patient-level costs are built. Products include clinical services from Appendix 4 of the Standard: ward stays, theatre procedures, outpatient visits, diagnostic investigations (e.g., EEG, ECG, lab tests), dispensed drugs, and allied health services.

STAGE 05

Allocate Costs to Patients

Using linking rules that connect clinical activity data (from EMR/HIS) to cost products, assign costs from each direct cost center to individual patient encounters. Every medication, every clinician minute, every diagnostic item must be traced to specific patient records.

STAGE 06

Review, Validate & Submit

Conduct rigorous data validation and reconciliation against audited financial statements before submission. Resolve all critical errors (which block submission) and address warning-level discrepancies. Submit the validated XML file through the DOH’s Shafafiya portal within the required submission window.

Technology Infrastructure: Shafafiya & Malaffi

Clinical costing in Abu Dhabi operates within a highly structured digital ecosystem. Two critical platforms sit at the center of compliance — and understanding how they relate is essential for any provider’s technology strategy.

Malaffi

Abu Dhabi’s Health Information Exchange (HIE) platform. Connects healthcare providers across the emirate through unified patient data exchange using HL7/FHIR interoperability standards. Provides the clinical data foundation that feeds into cost calculations — linking every clinical activity to its patient record.

Shafafiya

The DOH’s regulatory transparency portal. Used for submitting structured clinical costing data in the mandated XML format, as well as healthcare claims and other regulatory reports. All clinical costing submissions for patient-level cost data must pass through Shafafiya’s validation engine.

DRG Alignment & Value-Based Healthcare

The clinical costing mandate cannot be understood in isolation from the broader shift in how healthcare is funded and reimbursed in Abu Dhabi. The DOH’s agenda is explicitly value-based: providers should be rewarded for delivering high-quality care efficiently, not simply for the volume of services they perform.

How DRG and Clinical Costing Connect

Under a DRG payment model, a hospital receives a fixed payment for a patient admitted with, for example, a hip fracture requiring surgery — regardless of whether that patient stays two nights or fourteen. If the hospital’s actual cost of treating that patient exceeds the DRG payment, it absorbs the loss. If costs are lower, it retains the surplus.

Without clinical costing, hospitals are operating blind. They cannot identify which DRGs are profitable, which are loss-making, and where clinical practices need to change to improve financial sustainability. Clinical costing turns this guesswork into data-driven decision-making.

What Clinical Costing Data Enables

• Identify which clinical services, departments, and patient populations generate margin vs. losses
• Benchmark costs against DOH system-wide averages once cross-provider data is aggregated
• Negotiate more favorable DRG rates with insurers using evidence-based cost data
• Justify capital investment decisions based on procedure-level profitability
• Reduce claim rejections by ensuring internal costing aligns with billed amounts
• Drive clinical efficiency by identifying outlier practices within peer groups
• Support budgeting with granular, activity-driven cost intelligence

Penalties for Non-Compliance

Non-compliance with DOH clinical costing requirements can lead to serious financial and operational consequences.

Healthcare providers that miss submission deadlines may face penalties of AED 5,000 per day, while submissions with significant data quality issues can result in fines of up to AED 500,000.

Regulatory actions can escalate further depending on the severity of non-compliance. Failure to designate a clinical costing contact may trigger audits, while repeated non-submission can lead to operational restrictions, such as suspension of new patient admissions. In more severe cases, persistent or willful non-compliance may result in license revocation.

It is also important to note that submitting data on time is not enough — the DOH evaluates accuracy and consistency. Submissions that fail validation may still lead to penalties and mandatory resubmissions.

⚠️ Data Quality Is Not Enough — Accuracy Matters

Submitting data on time is necessary but not sufficient. The DOH’s validation engine will check every record for accuracy, consistency, and reasonableness. Submissions with systematic errors — even if filed on time — trigger significant penalties and mandatory re-submission at the provider’s cost.

Clinical Costing Implementation Support: How RITS & QC Centra Fit In

By now, it’s clear that clinical costing is not just a reporting task — it requires structured data, clear processes, and proper system integration.

For many providers, the real challenge is not understanding what to do, but executing it correctly and consistently.

This is where RITS supports healthcare organizations by aligning financial data, clinical activity, and DOH requirements into a structured and manageable system.

This typically involves:

• Defining cost centers and allocation methods
• Integrating data across HIS, ERP, and financial systems
• Ensuring reconciliation with general ledger data
• Preparing and validating data for Shafafiya submission

To support this, QC Centra streamlines the entire process by enabling structured data handling, validation, and submission readiness.

Instead of treating clinical costing as a one-time activity, this approach helps providers maintain continuous compliance readiness with better accuracy and reduced operational complexity.

FAQ

1. Is clinical costing mandatory for small clinics in Abu Dhabi?

Yes. All healthcare providers delivering direct patient care in Abu Dhabi — regardless of size — must comply with DOH clinical costing standards. There is no exemption based on bed count, revenue, or number of practitioners. If you hold a DOH license and treat patients, compliance is required.

2. Does Dubai have similar clinical costing requirements?

Currently, the mandatory clinical costing framework is specific to Abu Dhabi under DOH. There is no publicly confirmed equivalent from the Dubai Health Authority (DHA) or Ministry of Health (MOH). However, similar frameworks may be introduced in the future as part of broader healthcare reforms.

3. Do I need to replace my existing Hospital Information System (HIS)?

Not necessarily. Most clinical costing solutions work as middleware, integrating with your existing HIS, ERP, and financial systems. However, if your current systems lack proper data capture or integration capabilities, upgrades or enhancements may be required.

4. What data must be submitted for each patient encounter?

The DOH requires detailed patient-level cost data, including all resources consumed during care — such as medications, staff time, diagnostics, and overhead allocations. This data must be structured in XML format and linked to patient encounters, care settings, and facility details.

5. What happens if my Shafafiya submission is rejected?

A rejected submission is treated as non-compliance if not corrected within the submission window. Critical errors must be resolved before acceptance, while warning-level issues may trigger audits or follow-ups. Pre-validation is essential to avoid delays and penalties.

6. How does clinical costing differ from billing?

Billing reflects what a provider charges for services, while clinical costing reflects the actual cost of delivering those services. The difference between the two determines profitability, especially under fixed DRG payment models.

7. What is the deadline for DOH clinical costing submission?

Clinical costing submissions follow an annual reporting cycle defined by DOH. For FY2024, the submission window was September 1–30, 2025, following extensions. Future submissions are expected to follow standard timelines without extensions, making continuous readiness essential.